# US 2021/0231576 A1 · Detection and characterization of defects in pharmaceutical cylindrical containers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0231576 A1
- Document ID: US20210231576A1
- Status: Published application
- Kind: A1
- Application number: 17/157,080
- Filed: 2021-01-25
- Published: 2021-07-29
- Earliest claimed: 2020-01-23
- Assignees: SCHOTT Schweiz AG
- Applicants: SCHOTT Schweiz AG
- Inventors: Daniel Willmes
- Web page: https://patentgrep.com/patent/US20210231576A1

## CPC

- G01N 21/892: characterised by the flaw, defect or object feature examined
- G01N 21/90: in a container or its contents (G01N21/91 takes precedence)
- G01N 21/8901: {Optical details; Scanning details (per se G02B)}
- G01N 21/8914: {characterised by the material examined}
- G01N 21/952: Inspecting the exterior surface of cylindrical bodies or wires (G01N21/956 takes precedence)
- G01N 2021/8905: {Directional selective optics, e.g. slits, spatial filters}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An apparatus for inspecting a pharmaceutical cylindrical container made of a polymer, a specific method for inspecting a pharmaceutical cylindrical container made of a polymer and a specific bundle of pharmaceutical cylindrical containers made of a polymer.

## Claims

### Claim 1

An apparatus for inspecting a pharmaceutical cylindrical container made of a polymer, comprising:
a support device configured to support the pharmaceutical cylindrical container and rotate the cylindrical pharmaceutical container around a longitudinal axis;
a light emitting unit comprising a light source configured to illuminate the pharmaceutical cylindrical container with an inspection beam; and
a light receiving unit comprising a camera that receives light emitted by the pharmaceutical cylindrical container and acquires an image of the pharmaceutical cylindrical container.

### Claim 2 (depends on 1)

The apparatus of claim 1, wherein the support device, the light emitting unit, and the light receiving unit are configured to inspected the pharmaceutical cylindrical container in one second or less.

### Claim 3 (depends on 1)

The apparatus of claim 1, wherein the light source emits light comprising a wavelength in a range selected from a group consisting of 10 nm to 1000 nm, 100 nm to 400 nm, and 220 nm to 380 nm.

### Claim 4 (depends on 1)

The apparatus of claim 1, wherein the light source is a source selected from a group consisting of an ultraviolet gas-discharge lamp, an ultraviolet light-emitting diode, an ultraviolet laser, an ultraviolet light-emitting diode, an ultraviolet laser, and combinations thereof.

### Claim 5 (depends on 1)

The apparatus of claim 1, wherein the light receiving unit is configured to receive light emitted by the pharmaceutical cylindrical container having a wavelength in a range selected from a group consisting of 300 nm to 700 nm, 400 nm to 500 nm, and 430 nm to 460 nm.

### Claim 6 (depends on 1)

The apparatus of claim 1, wherein in the support device, the light emitting unit, and the light receiving unit are configured so that X=B−A,
wherein B is a wavelength of the light emitted by the pharmaceutical cylindrical container at a maximum, and
wherein A is a wavelength emitted by the light source of the light emitting unit at a maximum, and
X is in distance in a range selected from a group consisting of 50 nm to 500 nm, 75 nm to 500 nm, and 100 nm to 300 nm.

### Claim 7 (depends on 1)

The apparatus of claim 1, wherein the light receiving unit further comprises a lens, wherein the lens is permeable for light having a wavelength in a range selected from a group consisting of 200 nm to 900 nm, 400 nm to 800 nm, 400 nm to 500 nm, and 430 nm to 460 nm.

### Claim 8 (depends on 1)

The apparatus of claim 1, wherein the light receiving unit further comprises a filter, wherein the filter blocks light having a wavelength of 600 nm or more and/or a wavelength of 200 nm or less.

### Claim 9 (depends on 1)

The apparatus of claim 1, wherein the support device supports the pharmaceutical cylindrical container so that the longitudinal axis and a horizontal axis perpendicular to the longitudinal axis define a horizontal plane, and wherein the camera has a centerline that intersects the horizontal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less.

### Claim 10 (depends on 1)

The apparatus of claim 1, wherein the support device supports the pharmaceutical cylindrical container so that the longitudinal axis and a vertical axis perpendicular to the longitudinal axis define a vertical plane, and wherein the camera has a centerline that intersects the vertical plane at an angle of 60° or more and 90° or less, 70° or more and 90° or less, and 80° or more and 90° or less.

### Claim 11 (depends on 1)

The apparatus of claim 1, wherein the support device supports the pharmaceutical cylindrical container so that a horizontal axis perpendicular to the longitudinal axis and a vertical axis perpendicular to the longitudinal axis intersect a middle of a cylindrical part of the pharmaceutical cylindrical container at a transversal plane, and wherein the camera has a centerline that intersects the transversal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less.

### Claim 12 (depends on 1)

The apparatus of claim 1, wherein the inspection beam comprises unpolarized light.

### Claim 13

A method for inspecting a pharmaceutical cylindrical container made of a polymer, comprising:
illuminating the pharmaceutical cylindrical container with a light emitting unit;
receiving light emitted by the pharmaceutical cylindrical container with a light receiving unit to acquire a first image of the pharmaceutical cylindrical container; and
characterizing defects in and/or on the pharmaceutical cylindrical container based on the image.

### Claim 14 (depends on 13)

The method of claim 13, further comprising:
illuminating the pharmaceutical cylindrical container with the same and/or a further light emitting unit;
receiving light scattered by and/or transmitted through the pharmaceutical cylindrical container with the same or a further light receiving unit to acquire a second image of the pharmaceutical cylindrical container;
characterizing additional defects in and/or on the pharmaceutical cylindrical container based on the second image.

### Claim 15 (depends on 14)

The method of claim 14, wherein the first image and/or second image are analyzed to detect slides in the polymer of the pharmaceutical cylindrical container.

### Claim 16 (depends on 14)

The method of claim 14, further comprising controlling a process of manufacturing the pharmaceutical cylindrical container based on the first image and/or second image.

### Claim 17 (depends on 14)

The method of claim 14, further comprising disregarding, based on the first image and/or second image, any pharmaceutical cylindrical container exhibiting a value of Y and/or Z of 0.05 to 1.0,
wherein Y=A1/B1,
wherein A1 is a maximum length in cm of any slide in a cylindrical part of the pharmaceutical cylindrical container,
wherein B1 is a length in cm of the cylindrical part of the pharmaceutical cylindrical container,
wherein Z=A2/B2,
wherein A2 is an area in cm2 of any slides, and
wherein B2 is an area in cm2 of the cylindrical part.

### Claim 18 (depends on 17)

The method of claim 17, wherein the value of Y and/or Z is 0.5 to 1.0.

### Claim 19 (depends on 17)

The method of claim 17, wherein the value of Y and/or Z is 0.05 to 1.0.

### Claim 20 (depends on 14)

The method of claim 14, wherein the illuminating, receiving, and characterizing defects steps for each pharmaceutical cylindrical container are completed in 1 second or less.

### Claim 21

A bundle of pharmaceutical cylindrical containers made of a polymer, comprising:
ten or more pharmaceutical cylindrical containers; and
a value Y and/or a value Z of 0.5 or less,
wherein Y=A1/B1,
wherein A1 is a maximum length in cm of any slide in a cylindrical part of the pharmaceutical cylindrical container,
wherein B1 is a length of the cylindrical part of the pharmaceutical cylindrical container,
wherein Z=A2/B2,
wherein A2 is an area in cm2 of any slides in the cylindrical part, and
wherein B2 is an area in cm2 of the cylindrical part.

### Claim 22 (depends on 21)

The bundle of claim 21, wherein the pharmaceutical cylindrical containers are made of a polymer selected from a group consisting of a cycloolefin copolymer (COC), a cycloolefin polymer (COP), and a cycloolefin copolymer (COC).

### Claim 23 (depends on 21)

The bundle of claim 21, wherein the value of Y and/or Z is 0.2 or less.

### Claim 24 (depends on 21)

The bundle of claim 21, wherein the value of Y and/or Z is 0.1 or less.

### Claim 25 (depends on 21)

The bundle of claim 21, wherein the value of Y and/or Z is 0.05 or less.
